申请人:THE REGENTS OF THE UNIVERSITY OF MICHIGAN
公开号:US20190152947A1
公开(公告)日:2019-05-23
The present disclosure provides compounds by Formula (I): (Formula(I)) and the pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R
2
, R
3a
, R
3b
, A, G, X, and Y are as defined as set forth in the specification. The present disclosure also provides compounds of Formula (I) for use to treat a condition or disorder responsive to menin inhibition such as cancer.